Parametric Portfolio Associates’s 10x Genomics TXG Stock Holding History

Parametric Portfolio Associates’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$7.34M	Buy	96,475 +42,157	+78%	+$3.69M	﹤0.01%	1581
2021 Q4	$8.09M	Sell	54,318 -924	-2%	-$142K	﹤0.01%	1531
2021 Q3	$8.04M	Buy	55,242 +317	+0.6%	+$54.4K	﹤0.01%	1504
2021 Q2	$10.8M	Buy	54,925 +9,230	+20%	+$1.67M	0.01%	1327
2021 Q1	$8.27M	Buy	45,695 +16,645	+57%	+$2.87M	﹤0.01%	1811
2020 Q4	$4.11M	Buy	29,050 +5,557	+24%	+$806K	﹤0.01%	2201
2020 Q3	$2.93M	Buy	23,493 +7,934	+51%	+$833K	﹤0.01%	2263
2020 Q2	$1.39M	Buy	15,559 +5,572	+56%	+$434K	﹤0.01%	2731
2020 Q1	$622K	Sell	9,987 -7,063	-41%	-$551K	﹤0.01%	3045
2019 Q4	$1.3M	Sell	17,050 -963	-5%	-$57.9K	﹤0.01%	2922
2019 Q3	$908K	Buy	+18,013	New	+$997K	﹤0.01%	3078

Other funds holding TXG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parametric Portfolio Associates's TXG Position: Q1 2022 in Review

Parametric Portfolio Associates increased its 10x Genomics (TXG) stake by 78% in Q1 2022, buying an estimated $3.69M and bringing the position to 96,475 shares worth $7.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1581.

Parametric Portfolio Associates first reported a position in TXG in Q3 2019 and has held it in 11 quarters since. The position peaked at $10.8M in Q2 2021. 314 funds tracked by Wall St. Rank hold TXG as of Q1 2022.

Parametric Portfolio Associates held 96,475 shares of 10x Genomics worth $7.34M as of Q1 2022.
Parametric Portfolio Associates bought 42,157 10x Genomics shares in Q1 2022, an estimated $3.69M.
10x Genomics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1581 holding.
Parametric Portfolio Associates first reported a position in 10x Genomics in Q3 2019 and has held it in 11 quarters since.
Parametric Portfolio Associates's 10x Genomics position peaked at $10.8M in Q2 2021.
314 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.